9-135624293-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_182974.3(GLT6D1):c.635C>T(p.Pro212Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000442 in 1,605,094 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182974.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLT6D1 | NM_182974.3 | c.635C>T | p.Pro212Leu | missense_variant | 5/5 | ENST00000371763.6 | NP_892019.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLT6D1 | ENST00000371763.6 | c.635C>T | p.Pro212Leu | missense_variant | 5/5 | 1 | NM_182974.3 | ENSP00000360829.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000248 AC: 6AN: 242102Hom.: 0 AF XY: 0.0000229 AC XY: 3AN XY: 131136
GnomAD4 exome AF: 0.0000413 AC: 60AN: 1452848Hom.: 1 Cov.: 33 AF XY: 0.0000471 AC XY: 34AN XY: 721908
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2023 | The c.635C>T (p.P212L) alteration is located in exon 5 (coding exon 4) of the GLT6D1 gene. This alteration results from a C to T substitution at nucleotide position 635, causing the proline (P) at amino acid position 212 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at